RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Allergan Inc.

A collection of news and information related to Allergan Inc. published by this site and its partners.

Top Allergan Inc. Articles

Displaying items 23-33
  • Allergan urges shareholders to reject Valeant buyout offer

    Allergan Inc., the Irvine company that makes Botox, is urging shareholders to reject a buyout offer from a Canadian pharmaceutical firm. Valeant Pharmaceuticals International Inc. said last week that it will take its acquisition offer directly to...
  • Allergan urges shareholders to reject Valeant offer

    Allergan Inc., the Irvine company that makes Botox, is urging shareholders to reject a buyout offer from a Canadian pharmaceutical firm. Valeant Pharmaceuticals International Inc. has offered to buy all of Allergan’s shares for a combination of...
  • U.S. senators seek review of proposed Valeant buyout of Allergan

    Seven U.S. senators have asked the Justice Department and Federal Trade Commission to review the proposed acquisition of Botox maker Allergan Inc. by a Canadian company, saying the deal could increase consumer pricing and curtail the development of new...
  • Corporate tax scam watch: The 'inversion' craze

    Corporate tax scam watch: The 'inversion' craze
    Apple's done it. Herbalife has done it. Pfizer wanted to do it. What could be wrong with a corporate maneuver eyed by these fine, upstanding American corporations--and nearly 50 others in the last decade? The subject is "inversions," the catch-all...
  • Ackman turns up heat on Allergan, calls for shareholder meeting

    The jockeying for control of Botox maker Allergan Inc. is getting nastier. Activist investor Bill Ackman called Monday for a special meeting at which Allergan shareholders could potentially vote out the bulk of the Irvine company's board of directors....
  • Bid for Allergan turns hostile as Ackman calls for shareholder meeting

    The jockeying for control of Botox maker Allergan Inc. is getting downright hostile — and even more bizarre. Activist investor Bill Ackman called for a special meeting at which Allergan shareholders could potentially vote out the bulk of the...
  • Ackman warns Allergan on offer

    Activist investor Bill Ackman warned Botox maker Allergan Inc. on Monday that it would be unwise to court potential buyers as an alternative to the offer that he and Valeant Pharmaceuticals International Inc. have made for the company. Last month,...
  • Novartis, GSK announce multibillion-dollar overhaul of drug businesses

    Novartis, GSK announce multibillion-dollar overhaul of drug businesses
    Swiss pharmaceutical titan Novartis AG on Tuesday announced an overhaul of its operations that involved several multibillion-dollar deals with GlaxoSmithKline intended to allow Novartis to focus on its oncology business and boost profitability, the...
  • Ackman and Valeant make bid for Allergan

    Ackman and Valeant make bid for Allergan
    Activist investor Bill Ackman and his unlikely Canadian partner, Valeant Pharmaceuticals International Inc., unveiled details of their bid for Irvine pharmaceutical company Allergan Inc., which makes the popular Botox wrinkle treatment. Valeant will...
  • Allergan steps up attack on Valeant

    The billion-dollar takeover battle targeting Irvine-based Allergan is heading into high gear this week with both sides on the attack. On Tuesday, Allergan Inc., the maker of Botox, launched a broadside against Canadian rival Valeant Pharmaceutics...
  • Zimmer to buy Biomet amid flurry of billion-dollar medical deals

    Zimmer to buy Biomet amid flurry of billion-dollar medical deals
    Orthopedic products maker Zimmer Holdings on Thursday announced it will acquire Biomet Inc. in a deal valued at $13.35 billion, including assumption of debt, the companies said.    The proposed acquisition follows a flurry of billion-dollar deals by...